Aligos Therapeutics (ALGS) Capital Expenditures (QoQ) (2020 - 2023)
Aligos Therapeutics (ALGS) Capital Expenditures (QoQ) (2020 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Aligos Therapeutics |
51.70 Mn |
-28.13 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2023 |
-92.31% |
| Dec 31, 2022 |
2,933.33% |
| Sep 30, 2022 |
-99.10% |
| Jun 30, 2022 |
-35.15% |
| Mar 31, 2022 |
53.27% |
| Dec 31, 2021 |
246.39% |
| Sep 30, 2021 |
-36.18% |
| Jun 30, 2021 |
-50.49% |
| Mar 31, 2021 |
403.28% |
| Dec 31, 2020 |
-82.27% |
| Sep 30, 2020 |
-39.54% |
| Jun 30, 2020 |
-47.80% |
| Mar 31, 2020 |
-57.64% |
